Afferent Corporation Receives $750,000 Phase II SBIR Grant; NIH Provides Funding For New Technology Aimed At Stroke Rehabilitation
10/19/2005 5:08:58 PM
Afferent Corporation today announced that it has recently been awarded a Phase II Small Business Innovation Research (SBIR) grant of $750,000 from the National Institute of Neurological Disorders and Stroke (NINDS). NINDS is part of the National Institutes of Health (NIH) and is the primary supporter of biomedical research on the brain and nervous system in the U.S.
comments powered by